NCT04535934View on ClinicalTrials.gov

Novel Approaches for Quantitative Assessment of Adherence

CompletedOBSERVATIONAL
Enrollment

15

Participants

Timeline

Start Date

August 31, 2020

Primary Completion Date

November 15, 2022

Study Completion Date

November 15, 2022

Conditions
Healthy
Interventions
OTHER

Adenine 5+ (five stable-labeled nitrogens)

taggant coencapsulated with an excipient

Trial Locations (1)

80045

University of Colorado- Anschutz Medical Campus, Aurora

All Listed Sponsors
collaborator

National Institute of Allergy and Infectious Diseases (NIAID)

NIH

lead

University of Colorado, Denver

OTHER

NCT04535934 - Novel Approaches for Quantitative Assessment of Adherence | Biotech Hunter | Biotech Hunter